About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
On June 25, PhRMA sponsored The Atlantic’s People v. Cancer event, where Chief Operating Officer Lori Reilly led the fireside chat titled “Precision Oncology: The Future of Cancer Care.” Alongside Dan Asch, Vice President of Oncology Franchise at Boehringer Ingelheim, Lori discussed the promise of precision medicine in greatly improving cancer patient outcomes and advocated for policies that protect the oncology innovation pipeline.
When:
June 25, 2024, at 11:00 ET
Speakers:
- Dan Asch, Vice President of Oncology Franchise, Boehringer Ingelheim
- Lori Reilly, Chief Operating Officer, PhRMA